Picture of Verona Pharma logo

VRNA Verona Pharma Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Verona Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
R2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARS10-K10-K10-K
Standards:
IFRS
IFRS
USG
USG
USG
Status:
fx
Final
fx
Final
FinalFinalFinal
Revenue
Total Revenue000040
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses38.334.152.474.3113
Operating Profit-38.3-34.1-52.4-74.3-73.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-32.5-32.2-40.5-65-55.6
Provision for Income Taxes
Net Income After Taxes-26.4-26.5-40.6-65.1-55.6
Net Income Before Extraordinary Items
Net Income-26.4-26.5-40.6-65.1-55.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-26.4-26.5-40.6-65.1-55.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.301-0.252-0.39-0.25-0.117

Or unlock with your email

Or unlock with your email